Skip to content
Avril Biopharma, Inc.
  • About
  • Services & CapabilitiesExpand
    • Structural Genetics™
    • AdCEV™/Egg — Micro-production Platform
    • EggPharm Manufacturing Solutions
    • Covid-19 Response
  • Investors
Get Started
Avril Biopharma, Inc.

AfriVax

AfriVax | Ebola

Dr. Blyden presents at Bronx panel on Ebola

ByAvril Biopharma November 25, 2014August 10, 2022

The African Response to Ebola was a panel presentation organized by the Drammeh Nur Institute to raise awareness about Ebola…

Read More Dr. Blyden presents at Bronx panel on EbolaContinue

AfriVax | Ebola

AfriVax Supports Harlem Community Forum on Ebola

ByAvril Biopharma November 13, 2014August 10, 2022

On October, 30th AfriVax’s CEO Dr. Eluem Blyden made a presentation at the Community Forum “Ebola: What you need to…

Read More AfriVax Supports Harlem Community Forum on EbolaContinue

AfriVax | Ebola

April 2014: Minister of Health of Liberia Visits AfriVax Labs

ByAvril Biopharma August 6, 2014August 10, 2022

Our mission is to provide vertically integrated product development services to the global health community. We strive to have the…

Read More April 2014: Minister of Health of Liberia Visits AfriVax LabsContinue

Avril Biopharma is a future-of-medicine company developing the tools, platforms and products to enable biotechnology innovation.

Address: 333 15th St., Oakland CA 94612
Phone: (510) 833-4755

Services & Capabilities

  • Structural Genetics™
  • AdCEV™/Egg – Micro-Production Platform
  • EggPharm Manufacturing Solutions
  • Covid-19 Response

Company

  • About Us
  • Contact
  • Investors
  • Privacy Policy

Interested in learning more?

Contact Us

© 2023 Avril Biopharma, Inc.  All rights reserved. |  Privacy Policy  |  Credits

Facebook Linkedin Instagram Twitter
  • About
  • Services & Capabilities
    • Structural Genetics™
    • AdCEV™/Egg — Micro-production Platform
    • EggPharm Manufacturing Solutions
    • Covid-19 Response
  • Investors
Get Started